Chief Medical Editor Peter Kaiser, MD, will interview key retina surgeons regarding their clinical experience and honest conversations on managing patients during COVID, ensuring adherence to treatment regimens, how they talk to patients and handling durability during the pandemic.
E12: Treatment of Non-proliferative diabetic retinopathy in the Absence of DME
Description: Peter Kaiser, MD and Yasha Modi, MD discuss treatment of non-proliferative diabetic retinopathy in the absence of diabetic macular edema.
E11: The Treatment of Diabetic Retinopathy
Peter Kaiser, MD and Caroline Baumal, MD discuss the history and practice of treatment for diabetic retinopathy.
E10: The Port Delivery System and Wet AMD
Peter Kaiser, MD and Carol Regillo, MD, FACS discuss the port delivery system and how it impacts treatment of wet AMD.
E9: Treatment Options in the Covid Era
Peter Kaiser, MD and Christina Weng, MD discuss treatment options in the Covid era, AMD, and the durability of these treatments.
E8: The Challenge of Treating with Persistent Fluid
Peter Kaiser, MD, and Rishi Singh, MD assess treatment goal challenges with persistent fluid, accompanied with inability to extend injection intervals.
E7: Genentech’s New Port Delivery System
Peter Kaiser, MD, and Carl Awh, MD discuss what retina specialists can expect with the new Port Delivery System from Genentech.